Given the role of COX-2 in tumorigenesis in GBM, high COX-2 expression in GBM tumors is associated with poorer patient prognoses [160,187,188], although the GEPIA data showed no correlation between COX-1 and COX-2 expression and patient prognosis severity [9]. This evidence concerns the gene PTGS1 and glioblastoma.